Remote Medical Director, Neurology Clinical Research Lead

Sumitomo Pharma; Cheyenne (WY); Remote; USD 180,000 - 280,000; Full time

Job summary

Sumitomo Pharma America seeks a Medical Director, Clinical Research (Neurology) to lead neurology clinical development programs and act as the Clinical Research Lead for global studies. You will collaborate cross-functionally to shape trial design, safety monitoring, and regulatory submissions.

The role requires an MD with neurology board certification, epilepsy fellowship, and 1–2 years of pharma experience in clinical research strategy, with travel up to 20%.

Qualifications

• MD or international equivalent in Neurology.
• Board certified or board eligible in neurology.
• Fellowship training in epilepsy required.
• 1–2 years of pharmaceutical industry experience contributing to clinical research strategy in neurology.
• Experience in regenerative cell medicine or gene therapy preferred.

Responsibilities

• Leads critical workstreams and drives execution of neurology clinical development programs.
• Designs clinical study concepts and protocols across development stages.
• Provides SME input and leads multi-disciplinary teams in global trials.
• Oversees study conduct, interacts with CROs, monitors, and vendors.
• Contributes to data collection tools, data analysis, and eCRF design.
• Interprets data and writes clinical study reports.
• Collaborates on regulatory filings (BLA/NDAs, sNDAs, MAAs).
• Represents Clinical Research to internal and external stakeholders.

Education

MD/Neurology board certified

Job description

Sumitomo Pharma America seeks a Medical Director, Clinical Research (Neurology) to lead neurology clinical development programs and act as the Clinical Research Lead for global studies. You will collaborate cross-functionally to shape trial design, safety monitoring, and regulatory submissions.

The role requires an MD with neurology board certification, epilepsy fellowship, and 1–2 years of pharma experience in clinical research strategy, with travel up to 20%.